12.73 (-%)
As of Nov 21, 2024
Source:
Celcuity Inc is a clinical-stage biotechnology company focused on development of targeted therapies for treatment of multiple solid tumor indications. Our lead therapeutic candidate is gedatolisib, a pan-PI3K/mTOR inhibitor.
| Country | United States |
| Headquarters | minneapolis, minnesota |
| Phone Number | 763-392-0767 |
| Industry | services |
| CEO | Brian F. Sullivan |
| Website | www.celcuity.com |